Lexaria Bioscience LEXX
NASDAQ LEXX
$3.17 +0.04 (+1.44%)
As of: Sep 30, 2026 · 11:47 AM EDT

Lexaria Bioscience (LEXX) Convertible Debt (2016 - 2017)

Updated

Lexaria Bioscience's Convertible Debt was $45,000 in fiscal Q3 2017 (quarter ended May 31, 2017), unchanged from $45,000 a year earlier and unchanged from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Convertible Debt (2016 - 2017) Analysis & Trends

From fiscal Q3 2016 onward, Lexaria Bioscience has reported Convertible Debt for 5 quarters.

  • Per Business Quant data, LEXX's Convertible Debt in the three fiscal quarters before Q3 2017 was $45,000 (Q2 2017), $45,000 (Q1 2017) and $45,000 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lexaria Bioscience 3.39 Mn -12.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2017 45,000.00
Feb 28, 2017 45,000.00
Nov 30, 2016 45,000.00
Aug 31, 2016 45,000.00
May 31, 2016 45,000.00
API Access

Lexaria Bioscience Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LEXX&period=max&api_key=YOUR_API_KEY